sat-3247
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 21, 2024 (NCT06565208)
Timeline
Indications
Studied for
Mechanism of action
- Adaptor-associated kinaseINHIBITOR
AAK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07287189 | Phase 2 | Dec 8, 2025 | Satellos Bioscience |
| NCT06867107 | Phase 2 | May 1, 2025 | Satellos Bioscience |
| NCT06565208 | Early Phase 1 (Phase 1) | Aug 21, 2024 | Satellos Bioscience |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Satellos Bioscience | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1